Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Initial public offerings from oil-and-gas company Infinity Natural Resources Inc. and medical-device maker Beta Bionics Inc. both rose in their stock markets debut Friday, as they brushed aside losses ...

The IPO comes amid a deregulatory push in the energy sector by President Donald Trump, who repeated the "drill, baby, drill" slogan in his inaugural address. Earlier this week, Sean Duffy, the newly ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...

Diet Coke is having a moment as the drink of choice for Donald Trump, but daily consumption may carry risks, including ...

Maintaining healthy blood sugar levels and managing weight have become paramount for overall health and well-being in today’s fast-paced world. With the rising prevalence of diabetes and obesity, ...